A Pharmacokinetics/Dynamics Ib Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

NCT02522234 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Neutropenia

Interventions

BIOLOGICAL: F-627 240 μg/kg
BIOLOGICAL: F-627 320 μg/kg

Sponsor

EVIVE Biotechnology

Collaborators

[object Object]
[object Object]